Hiroshi Soeda - Concepedia

Author

Hiroshi Soeda

Tohoku University Hospital

Also Known As

H Soeda, H. Soeda, HIROSHI SOEDA, Hiroshi SOEDA, Hiroshi Soeda, Hitoshi Soeda

Publications

336

Citations

H-Index

Concepts

All Affiliations

Tohoku University Hospital Tohoku University Akita University Tochigi Medical Center

About

Hiroshi Soeda is an author at Tohoku University Hospital specializing in medicine, radiation oncology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	165
2	Engineering	1	1	82
3	Biochemistry	1	1	82
4	Biomolecular Engineering	1	1	82
5	Cell Biology	1	1	12

Hiroshi Soeda

Publications

283

Citations

H-Index

Page 1

	Year	Citations
MODIFIED ETHANOL INJECTION METHOD FOR LIPOSOMES CONTAINING β-SITOSTEROL β-D-GLUCOSIDE Yoshie Maitani, Hiroshi Soeda, Wan Jun-ping, Journal of Liposome Research Lipid PreparationEngineeringConcanavalin ABiochemistryMedicine	2001	82
Preliminary estimation of the prevalence of chemotherapy-induced dysgeusia in Japanese patients with cancer Hiroo Imai, Hiroshi Soeda, Keigo Komine, BMC Palliative Care	2013	47
Clinical usefulness of KRAS, BRAF, and PIK3CA mutations as predictive markers of cetuximab efficacy in irinotecan- and oxaliplatin-refractory Japanese patients with metastatic colorectal cancer Hiroshi Soeda, Hideki Shimodaira, Mika Watanabe, International Journal of Clinical Oncology Cetuximab EfficacyMedicinePathologyColorectal CancerMetastatic Colorectal Cancer	2012	35
Ability of suvorexant to prevent delirium in patients in the intensive care unit: a randomized controlled trial Kazunari Azuma, Yoshikazu Takaesu, Hiroshi Soeda, Acute Medicine & Surgery	2018	33
CpG island methylator phenotype is associated with the efficacy of sequential oxaliplatin- and irinotecan-based chemotherapy and EGFR-related gene mutation in Japanese patients with metastatic colorectal cancer Xiaofei Zhang, Hideki Shimodaira, Hiroshi Soeda, International Journal of Clinical Oncology Egfr-related Gene MutationMedicinePathologyColorectal CancerMetastatic Colorectal Cancer	2016	24
Phase II Trial of Cetuximab plus Irinotecan for Oxaliplatin- and Irinotecan-Based Chemotherapy-Refractory Patients with Advanced and/or Metastatic Colorectal Cancer: Evaluation of Efficacy and Safety Based on <b><i>KRAS</i></b> Mutation Status (T-CORE0801) Hiroshi Soeda, Hideki Shimodaira, Makio Gamoh, Oncology	2014	20
Acromegaly, diabetes insipidus, and visual loss caused by metastatic growth hormone—releasing hormone-producing malignant pancreatic endocrine tumor in the pituitary gland Shigeru Genka, Hiroshi Soeda, Manabu Takahashi, Journal of neurosurgery	1995	18
Practical utility of circulating tumour cells as biomarkers in cancer chemotherapy for advanced colorectal cancer. Kazunori Otsuka, Hiroo Imai, Hiroshi Soeda, PubMed PathologyStage Iv CrcBiomarker TestingAdvanced Colorectal CancerTumor Biology	2013	12
Gene-expression profiles correlate with the efficacy of anti-EGFR therapy and chemotherapy for colorectal cancer Masahiro Inoue, Shin Takahashi, Hiroshi Soeda, International Journal of Clinical Oncology Tumor BiologyMedicinePathologyColorectal CancerGene-expression Profiles	2015	12

Page 1